GRAIL, Inc. Financing Cash Flow
GRAIL, Inc. (GRAL) reported Financing Cash Flow of $113.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- GRAIL, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $423.32M.
- GRAIL, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00.
- GRAIL, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- GRAIL, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- GRAIL, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $423.32M, a 65.98% decline from fiscal 2024.
- GRAIL, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $1.24B, a 168.30% increase from fiscal 2023.
- GRAIL, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $463.77M, a 23.32% decline from fiscal 2023.
- GRAIL, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $604.82M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $113.61M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $423.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $423.32M derived: sum of 2 quarters · filed 2026-03-12 | $423.32M derived: sum of 3 quarters · filed 2026-08-06 | $423.32M 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $932.30M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $932.30M derived: sum of 3 quarters · filed 2026-03-12 | $1.24B 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $932.30M derived: sum of 2 quarters · filed 2025-11-13 | $1.24B 10-Q · filed 2025-11-13 | $1.33B derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | $932.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.24B 10-Q · filed 2025-08-13 | $1.33B derived: sum of 3 quarters · filed 2026-03-12 | $1.40B derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $312.00M 10-Q · filed 2025-05-14 | $397.99M derived: sum of 2 quarters · filed 2026-03-12 | $471.99M derived: sum of 3 quarters · filed 2026-03-12 | |
| 2023-12-31 | $85.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $159.99M derived: sum of 2 quarters · filed 2026-03-12 | $463.77M 10-K · filed 2025-03-05 | |
| 2023-10-01 | $74.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $377.78M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $303.77M 10-Q · filed 2024-08-13 | |||
| 2023-01-01 | $604.82M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |